However, there is evidence that CXCR-4 can induce de novo lymphangiogenesis and angiogenesis within the tumor or secondary site in pancreatic cancer, which may be favorable for lymphatic invasion [16]. This evidence concerns the gene CXCR4 and familial pancreatic carcinoma.